user-group INVESTOR ACCESS
Search
Close this search box.
  1. Home
  2. /
  3. Venture Capital
  4. /
  5. BIOPHTA raises 6.5 million...

News / Venture Capital

BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage.

3 June 2024
BIOPHTA, a preclinical biotech company developing a game-changing technology for the treatment of eye diseases, has just closed a € 6.5 million Seed round to bring its patented technology to clinical development.

Download

Press Release
Download

Related News

  • Buyout
Icone-Merieux-partners
  • Buyout

Mérieux Equity Partners announces two promotions to strengthen its Buyout Team

arrow-up-right
  • Buyout
GTP_Bioways_3-vector
  • Recent investments & divestments

Mérieux Equity Partners announces the sale of the French Contract Developing and Manufacturing Organisation GTP Bioways to the Italian company Olon Group

arrow-up-right
  • Buyout
labquality logo
  • Recent investments & divestments

Labquality strengthens its regulatory affairs service capabilities and expands to Sweden.

arrow-up-right
Lyon
Paris
Contact
  • ⓒ MERIEUX EQUITY PARTNERS 2023
  • Mérieux Equity Partners vehicles are only open to Professional Clients - as defined in the French Monetary code (CMF) and AMF regulation (RG).